Bristol Myers Squibb (BMY) Retained Earnings (2009 - 2026)

Bristol Myers Squibb (BMY) has reported Retained Earnings for 18 consecutive years, with $46.5 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Retained Earnings rose 0.8% year-over-year to $46.5 billion in Q2 2026; TTM through Jun 2026 was $46.5 billion, a 0.8% increase from a year earlier, with the FY2025 full-year figure at $46.4 billion, up 0.79% from the prior year.
• Retained Earnings was $46.5 billion for Q2 2026 at Bristol Myers Squibb, roughly flat from $46.4 billion in the prior quarter.
• Over five years, Retained Earnings peaked at $46.5 billion in Q2 2026 and troughed at $43.8 billion in Q1 2022.
• A 5-year average of $45.6 billion and a median of $45.7 billion in 2023 frame the typical range for Retained Earnings.
• The widest YoY moves for Retained Earnings: up 3.16% in 2023, down 0.24% in 2023.
• Over 5 years, Retained Earnings stood at $45.2 billion in 2022, then climbed by 1.15% to $45.7 billion in 2023, then climbed by 0.74% to $46.0 billion in 2024, then climbed by 0.79% to $46.4 billion in 2025, then rose by 0.25% to $46.5 billion in 2026.
• The last three Retained Earnings figures came in at $46.5 billion (Q2 2026), $46.4 billion (Q1 2026), and $46.4 billion (Q4 2025), per Business Quant data.